Go Back

Company or ticker...

Iovance Biotherapeutics

Iovance develops and sells cancer treatments that use a patient's own immune cells to attack tumors.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

IOVA

3.7B

11.4

n/a

189.57%

Key Facts

M. Cap

PS

PE

YTD

3.7B

11.4

n/a

189.57%

10MA

20MA

50MA

200MA

$IOVA

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now